Julien Miara is the interim CEO of Valerio Therapeutics and is a Principal at Invus. He joined in 2010 as an analyst in the Public Equity group, covering Biotechnology among other sectors.

Since 2018, Julien leads the team in Europe. Previously, he worked in investment banking at BNP Paribas in Paris and Société Générale in New-York, as well as in management consulting. Julien Miara received his Master of Management from EDHEC Business School in Lille (France) in 2009.

At its meeting on September 17, 2020, the Board of Directors of Valerio Therapeutics co-opted Mr. Julien Miara as a director of the Company. This cooptation was ratified by the Company’s ordinary general meeting of June 10, 2021.

Mr. Julien Miara was appointed as interim CEO of Valerio Therapeutics on January 3, 2022.